Reverse targeting lipid vesicle

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/385 (2006.01) A61K 9/127 (2006.01) A61P 37/02 (2006.01) A61P 37/06 (2006.01) A61P 37/08 (2006.01)

Patent

CA 2660804

Disclosed is a immunomodulating agent or a therapeutic agent for an immune disease, which comprises a lipid vesicle including therein a substance capable of inhibiting or killing an immunocyte that expresses or binds to an antibody and having an antigen for the antibody bound to the outer surface thereof. It becomes possible to provide a means for treating an immune disease such as an allergic disease and autoimmune disease effectively.

La présente invention concerne un agent d'immunomodulation ou un agent thérapeutique pour maladie immune, qui comprend une vésicule de lipide comprenant à l'intérieur une substance capable d'inhiber ou de tuer un immunocyte qui exprime un anticorps ou qui se lie à celui-ci et possédant un antigène pour cet anticorps lié à la surface extérieure de celui-ci. Cette invention permet de traiter efficacement une maladie immune telle qu'une maladie allergique et une maladie auto-immune.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Reverse targeting lipid vesicle does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reverse targeting lipid vesicle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reverse targeting lipid vesicle will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1371452

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.